(19)
(11) EP 3 280 420 A1

(12)

(43) Date of publication:
14.02.2018 Bulletin 2018/07

(21) Application number: 16777382.9

(22) Date of filing: 08.04.2016
(51) International Patent Classification (IPC): 
A61K 31/57(2006.01)
C07J 7/00(2006.01)
A61P 25/00(2006.01)
(86) International application number:
PCT/US2016/026705
(87) International publication number:
WO 2016/164763 (13.10.2016 Gazette 2016/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 10.04.2015 US 201562146034 P
24.07.2015 US 201562196591 P
20.01.2016 US 201662280825 P

(71) Applicant: Sage Therapeutics, Inc.
Cambridge, MA 02142 (US)

(72) Inventors:
  • ROBICHAUD, Albert, Jean
    Cambridge, MA 02141 (US)
  • SALITURO, Francesco, G.
    Marlborough, MA 01752 (US)
  • MARTINEZ BOTELLA, Gabriel
    Wayland, MA 01778 (US)
  • HARRISON, Boyd, L.
    Princeton Junction, NJ 08550 (US)
  • JONAS, Jeffrey
    Cambridge, MA (US)

(74) Representative: Hucker, Charlotte Jane et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS